Rigel Pharmaceuticals Inc (NASDAQ:RIGL) showed up in the 13F filings of 192 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 1,768,907 | 104,697 | 6.29% | $47,831,252.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,664,210 | -60,688 | -3.52% | $71,278,114.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 1,343,756 | 606,721 | 82.32% | $57,553,070.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 1,280,000 | 444,000 | 53.11% | $34,611,200.00 |
| State Street Corp | 31 Mar, 2026 | 1,120,238 | 29,015 | 2.66% | $30,291,236.00 |
| State Street Corp | 31 Mar, 2026 | 1,091,223 | 536,905 | 96.86% | $46,737,081.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 1,038,408 | -4,715 | -0.45% | $44,475,015.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 836,000 | 112,000 | 15.47% | $35,805,880.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 764,193 | 764,193 | 0.00% | $20,663,779.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 666,426 | 172,822 | 35.01% | $18,009.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 613,600 | 12,267 | 2.04% | $26,280,489.00 |
| LSV ASSET MANAGEMENT | 31 Mar, 2026 | 601,507 | 57,225 | 10.51% | $16,265.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 598,378 | -15,222 | -2.48% | $16,180,140.00 |
| AMERICAN CENTURY COMPANIES INC | 31 Mar, 2026 | 544,431 | 289,939 | 113.93% | $14,721,414.00 |
| LSV ASSET MANAGEMENT | 31 Mar, 2026 | 544,282 | 433,382 | 390.79% | $23,312.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 539,009 | 64,800 | 13.66% | $23,085,755.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Mar, 2026 | 493,604 | -192,114 | -28.02% | $21,132.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 445,678 | 21,362 | 5.03% | $12,051,133.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 440,626 | 16,312 | 3.84% | $11,917,730.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 439,101 | -904,655 | -67.32% | $11,873,291.00 |